PLUS1
89.42
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agilent Technologies | A | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.50 | -0.56% | 89.42 | 88.57 | 89.87 | 89.41 | 89.92 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,004 | 940,432 | $ 89.07 | $ 83,763,026 | 1,902,198 | 61.63 - 93.04 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 134,771 | $ 89.42 | USD |
Agilent Technologies Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 27.61B | 308.78M | 307.66M | $ 5.16B | $ 670.16M | 3.37 | 40.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 4.39M | $ 0.66 | 0.74% | - | - |
Agilent Technologies News
| Date | Time | Source | News Article |
|---|---|---|---|
| 7/01/2020 | 12:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/08/2020 | 14:09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 6/04/2020 | 16:07 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 6/02/2020 | 16:34 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 6/02/2020 | 16:30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) |
| 6/01/2020 | 16:30 | Business Wire | Agilent Technologies Announces Pricing of $500 Million of.. |
| 6/01/2020 | 16:22 | Edgar (US Regulatory) | Free Writing Prospectus - Filing Under Securities Act Rules.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical A Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 89.02 | 90.64 | 88.56 | 89.47 | 1,225,758 | 0.40 | 0.45% |
| 1 Month | 86.83 | 90.64 | 83.71 | 87.90 | 1,409,750 | 2.59 | 2.98% |
| 3 Months | 80.09 | 93.04 | 73.42 | 83.64 | 1,924,209 | 9.33 | 11.65% |
| 6 Months | 87.72 | 93.04 | 61.63 | 79.67 | 2,232,654 | 1.70 | 1.94% |
| 1 Year | 73.58 | 93.04 | 61.63 | 77.34 | 2,157,550 | 15.84 | 21.53% |
| 3 Years | 59.48 | 93.04 | 58.22 | 71.58 | 2,058,157 | 29.94 | 50.34% |
| 5 Years | 39.29 | 93.04 | 33.115 | 60.80 | 2,035,043 | 50.13 | 127.59% |
Agilent Technologies Description
| Agilent Technologies Inc has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations. |
